Tallat Mahmood, MD

Specialty: Medical Oncology
Medical Director of Oncology, Ellis Hospital
Affiliate Assistant Professor of Oncology
Department of Hematology/Oncology
Ellis Hospital

 Request an Appointment
Locations

Roswell Park Main Campus
1-800-ROSWELL (1-800-767-9355)

Specializing In:

  • Quality of life in cancer survivors
  • Lung cancer
  • Advance care planning in oncology
  • Quality initiatives

Research Interests:

  • Lung cancer

Biography

I worked for 20 years in Michigan before moving to New York. I was involved in many reasearch projects as a Principal Investigator. I was on the steering committee for Michigan Quality Improvement Consortium, and particapated in several quality improvement projects. I love the cutting-edge aspect of clinical trials.

Positions

Roswell Park Care Network

  • Medical Director of Oncology, Ellis Hospital
  • Affiliate Assistant Professor of Oncology
  • Department of Hematology/Oncology
  • Ellis Hospital

Background

Education and Training

  • 1991 - MBBS - Aga Khan University Hospitals, Karachi, Pakistan

Residency

  • 1995-1997 - Internal Medicine - West Virginia University, Morgantown, WV

Fellowship

  • 1999-2000 - Tulane University, New Orleans, LA
  • 1997-1999 - Hematology/Oncology - Tulane University, New Orleans, LA

Board Certification

  • Internal Medicine
  • Hematology
  • Oncology

Professional Memberships

  • American Society of Clinical Oncology (ASCO)
  • American Society of Hematology (ASH)
  • American College of Physicians (ACP)

Honors & Awards

  • Teaching award from State University of New York Upstate Medical University, Syracuse, NY

Publications

“Early Clinical Support for 4-Demethyl4-Cholesteryloxyarbonylpenclomidine (DM-CHOC- PEN)as a radiosensitizer in Cancers Involving the CNS” AACR 2017 (Proc of Amer. Assoc. Cancer Res. 57, Abst #4746, 2017)

“Improving oral oncolytic patient self-management”, Journal of Oncology Practice, august 2016, 12(8)

Poster presentation at ASCO’s annual Palliative care Conference “Monitoring of Oral
Chemotherapy in a “Community private practice”, October 2014